Mast cell activation disorders (MCAD) encompass a wide range of immune-mediated conditions characterized by episodic or chronic mast cell activation, ...

Cogent Biosciences, Inc. (($COGT)) announced an update on their ongoing clinical study. Cogent Biosciences, Inc. is conducting a Phase 2 clinical ...

Sanofi posted strong Q3 results amid currency challenges; discover key pipeline updates and growth prospects for investors.

Hoth Therapeutics, Inc. (NASDAQ: HOTH) today highlighted FDA Orphan Drug Designation for HT-KIT and new preclinical data demonstrating >80% suppression of KIT expression and significant tumor-volume ...

Hoth Therapeutics (HOTH) highlighted FDA Orphan Drug Designation for HT-KIT and new preclinical data demonstrating greater than80% suppression of ...

Detailed results from bezuclastinib’s positive SUMMIT trial evaluating bezuclastinib in patients with NonAdvanced Systemic ...

Medscape Live is bringing back-to-back educational programs to San Diego next month focused on indolent systemic mastocytosis, or ISM.

Investing.com -- Cogent Biosciences Inc (NASDAQ:COGT) stock surged 8.3% in Monday’s premarket trading after the company announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough ...

Detailed results from bezuclastinib's positive SUMMIT trial evaluating bezuclastinib in patients with NonAdvanced Systemic Mastocytosis planned for presentation at upcoming scientific conference this ...

Peacock’s Devil in Disguise: John Wayne Gacy tells the chilling true story of a Chicago contractor who hid behind the mask of a friendly neighbor and community volunteer while preying on vulnerable ...